Details werden geladen...
Duchenne muscular dystrophy: ‘Breakthrough’ drug for severe muscle wasting condition set for NHS rollout in England | The Independent
Givinostat will be made available to eligible patients with Duchenne muscular dystrophy after its manufacturer struck a commercial deal with NHS England
Ähnliche Seiten
Pioneering drug for severe muscle wasting condition approved for NHS use | The Independent
https://www.independent.co.uk/bulletin/news/duchenne-muscular-dystrophy-dmd-duvyzat-drug-b2972947.htmlBreakthrough for prostate cancer patients as NHS now offers life-extending drug | The Independent
https://www.independent.co.uk/news/health/prostate-cancer-talazoparib-treatment-drug-nhs-b2906294.htmlBreakthrough treatment could help children with rare condition ‘lead happier lives’ | The Independent
https://www.independent.co.uk/bulletin/news/dravet-syndrome-epilepsy-treatment-drug-zorevunersen-b2932286.htmlNHS trusts in England failing to meet crucial cancer treatment target | The Independent
https://www.independent.co.uk/bulletin/news/nhs-trust-cancer-waiting-times-b2927054.htmlLife-extending prostate cancer drug to be made available to thousands more patients | The Independent
https://www.independent.co.uk/news/health/prostate-cancer-abiraterone-drug-nhs-hormone-therapy-b2902156.html